Professional Seasonal Analysis for Trading

Arcutis Biotherapeutics, Inc. - Common stock (ARQT)

Seasonality Analysis

Stocks 7 Years Analyzed

Arcutis Biotherapeutics, Inc. - Common stock Annual Seasonality Statistics

27.71%
Avg Annual Return
49.0%
Avg Monthly Win Rate
8/12
Positive Months
7
Years Analyzed

Arcutis Biotherapeutics, Inc. - Common stock Monthly Seasonality Performance

Month Avg Return Win Rate Strength
January 4.00%
33%
Weak
February 11.55%
71%
Very Strong
March -4.47%
43%
Weak
April 5.52%
57%
Moderate
May -10.25%
17%
Very Weak
June 5.99%
67%
Strong
July 3.27%
67%
Strong
August 4.16%
50%
Weak
September -4.59%
50%
Weak
October WORST -16.10%
17%
Very Weak
November 11.27%
50%
Weak
December BEST 17.36%
67%
Strong

Arcutis Biotherapeutics, Inc. - Common stock 2026 vs Historical Pattern

Current Position
37.42
Historical Avg Position
52.98
Deviation
-15.56
Performance
Significantly Below Average

Arcutis Biotherapeutics, Inc. - Common stock Interactive Seasonality Chart

Interactive Seasonality Chart

Unlock the full interactive seasonality chart for ARQT with overlay patterns, custom date ranges, and more.

Create Free Account

Arcutis Biotherapeutics, Inc. - Common stock Pattern Scanner

Pattern Scanner

Discover recurring patterns, anomalies, and statistically frequent setups.

Create Free Account

Arcutis Biotherapeutics, Inc. - Common stock Seasonal Historical Performance

Historical Performance

See historical average returns for ARQT across multiple timeframes.

Create Free Account

About Arcutis Biotherapeutics, Inc. - Common stock (ARQT) Seasonality

Arcutis Biotherapeutics, Inc. - Common stock (ARQT) has been analyzed using 7 years of historical data to identify seasonal patterns. Classified under Stocks, Arcutis Biotherapeutics, Inc. - Common stock shows distinct seasonal tendencies based on historical data.

The strongest month for Arcutis Biotherapeutics, Inc. - Common stock is historically December, with an average return of 17.36% and a win rate of 67%. Conversely, October tends to be the weakest month, averaging -16.10% return.

Looking at the full calendar year, Arcutis Biotherapeutics, Inc. - Common stock has an average annual return of 27.71% with an overall monthly win rate of 49.0%. Out of 12 months, 8 typically show positive average returns.

The seasonal pattern for Arcutis Biotherapeutics, Inc. - Common stock has a consistency score of 47.8 (Poor), based on 7 years of data. Higher consistency means the seasonal pattern has been more reliable across different market conditions.

Arcutis Biotherapeutics, Inc. - Common stock Seasonality FAQ

What is the best month to buy Arcutis Biotherapeutics, Inc. - Common stock (ARQT)?

Historically, December has been the best month for Arcutis Biotherapeutics, Inc. - Common stock, with an average return of 17.36% and a win rate of 67%. However, past performance does not guarantee future results.

What is the worst month for Arcutis Biotherapeutics, Inc. - Common stock (ARQT)?

Based on historical data, October has been the weakest month for Arcutis Biotherapeutics, Inc. - Common stock, with an average return of -16.10%. This is a historical observation and does not guarantee future results.

How reliable is ARQT seasonality data?

The seasonality analysis for Arcutis Biotherapeutics, Inc. - Common stock is based on 7 years of historical price data. While seasonal patterns can provide useful insights, they should be combined with other forms of analysis. Past patterns do not guarantee future performance.

How can I use Arcutis Biotherapeutics, Inc. - Common stock seasonality in my trading?

Use Arcutis Biotherapeutics, Inc. - Common stock (ARQT) seasonality as one factor in your analysis. Identify historically strong and weak months, combine with other research methods. SeasOptima provides premium tools including interactive charts, pattern scanning, and historical performance data for deeper analysis.

More Stocks Seasonality Analysis

Statistical information based on historical data. Does not constitute investment advice or recommendation. Past performance does not guarantee future results.